Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus

NCT04389580 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Drug: Isotretinoin plus Tamoxifen
DRUG: Aerosolized Isotretinoin plus Tamoxifen

Sponsor

Kafrelsheikh University